Development and characterization of surface engineered PPI dendrimers for targeted drug delivery

References

• Bagre AP, Jain K, Jain NK. 2013. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Int J Pharm. 456:31–40.
   PubMed Web of Science ®Google Scholar
• Bajwa N, Mehra NK, Jain K, Jain NK. 2015. Pharmaceutical and biomedical applications of quantum dots. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1052468.
   Web of Science ®Google Scholar
• Barbosa JA, Zoppi A, Quevedo MA, de Melo PN, de Medeiros AS, Streck L, et al. 2014. Triethanolamine stabilization of methotrexate-β-cyclodextrin interactions in ternary complexes. Int J Mol Sci. 15:17077–17099.
   PubMed Web of Science ®Google Scholar
• Chahal S, Hussain FSJ, Yusoff MBM. 2013. Characterization of modified cellulose (Mc)/poly (vinyl alcohol) electrospun nanofibers for bone tissue engineering. Proc Eng. 53:683–688.
   Google Scholar
• De Brabander‐van den Berg E, Meijer E. 1993. Poly(propylene imine) dendrimers: large‐scale synthesis by hetereogeneously catalyzed hydrogenations. Ange Chemie Int Edn Eng. 32:1308–1311.
   Web of Science ®Google Scholar
• Feng D, Song Y, Shi W, Li X, Ma H. 2013. Distinguishing folate-receptor-positive cells from folate-receptor-negative cells using a Fluorescence off-on nanoprobe. Anal Chem. 85:6530–6535.
   PubMed Web of Science ®Google Scholar
• Gajbhiye V, Ganesh N, Barve J, Jain NK. 2013. Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers. Eur J Pharm Sci. 48:668–679.
   PubMed Web of Science ®Google Scholar
• Gupta U, Dwivedi SKD, Bid HK, Konwar R, Jain N. 2010. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Int J Pharm. 393:186–197.
   Web of Science ®Google Scholar
• Hu D, Sheng Z, Fang S, Wang Y, Gao D, Zhang P, et al. 2014. Folate receptor-targeting gold nanoclusters as fluorescence enzyme mimetic nanoprobes for tumor molecular colocalization diagnosis. Theranostics. 4:142–153.
   PubMed Web of Science ®Google Scholar
• Jain A, Jain K, Kesharwani P, Jain NK. 2013a. Low density lipoproteins mediated nanoplatforms for cancer targeting. J Nanopart Res. 15:1–38.
   Web of Science ®Google Scholar
• Jain A, Jain K, Mehra NK, Jain NK. 2013b. Lipoproteins tethered dendrimeric nanoconstructs for effective targeting to cancer cells. J Nanopart Res. 15:2003.
   Web of Science ®Google Scholar
• Jain K, Gupta U, Jain NK. 2014. Dendronized nanoconjugates of Lysine and folate for treatment of cancer. Eur J Pharm Biopharm. 87:500–509.
   PubMed Web of Science ®Google Scholar
• Jain K, Jain NK. 2013. Novel therapeutic strategies for treatment of visceral leishmaniasis. Drug Discov Today. 18:1272–1281.
   PubMed Web of Science ®Google Scholar
• Jain K, Jain NK. 2014. Surface engineered dendrimers as antiangiogenic agent and carrier for anticancer drug: dual attack on cancer. J Nanosci Nanotechnol. 14:5075–5087.
   PubMed Web of Science ®Google Scholar
• Jain K, Jain NK. 2015. Vaccines for visceral leishmaniasis: a review. J Immunol Methods. 422:1–12.
   PubMed Web of Science ®Google Scholar
• Jain K, Kesharwani P, Gupta U, Jain N. 2010. Dendrimer toxicity: let's meet the challenge. Int J Pharm. 394:122–142.
   PubMed Web of Science ®Google Scholar
• Jain K, Mehra NK, Jain NK. 2015c. Nanotechnology in drug delivery: safety and toxicity issues. Curr Pharm Des. 21:4252–4261.
   PubMed Web of Science ®Google Scholar
• Jain K, Verma AK, Mishra PR, Jain NK. 2015a. Surface engineered dendrimeric nanoconjugates for macrophage targeted delivery of amphotericin B: formulation development, in vitro and in vivo evaluation. Antimicrob Agents Chemother. 59:2479–2487.
   PubMed Web of Science ®Google Scholar
• Jain K, Verma AK, Mishra PR, Jain NK. 2015b. Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers. Nanomedicine. 11:705–713.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Jain K, Jain NK. 2014. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci. 39:268–307.
   Web of Science ®Google Scholar
• Li MH, Choi SK, Thomas TP, Desai A, Lee KH, Kotlyar A, Holl MMB, Baker JR. 2012. Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting. Eur J Med Chem. 47:560–572.
   PubMed Web of Science ®Google Scholar
• Liu L, Zheng M, Renette T, Kissel T. 2012. Modular synthesis of folate conjugated ternary copolymers: polyethylenimine-graft-polycaprolactone-block-poly (ethylene glycol)-folate for targeted gene delivery. Bioconjugate Chem. 23:1211–1220.
   PubMed Web of Science ®Google Scholar
• Maruyama K. 2011. Intracellular targeting delivery of Liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev. 63:161–169.
   PubMed Web of Science ®Google Scholar
• Mehra NK, Jain K, Jain NK. 2015. Pharmaceutical and biomedical applications of surface engineered carbon nanotubes. Drug Discov Today. 20:750–759.
   PubMed Web of Science ®Google Scholar
• Mout R, Moyano DF, Rana S, Rotello VM. 2012. Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev. 41:2539–2544.
   PubMed Web of Science ®Google Scholar
• Perumal OP, Inapagolla R, Kannan S, Kannan RM. 2008. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials. 29:3469–3476.
   PubMed Web of Science ®Google Scholar
• Ryu JS, Raucher D. 2015. Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications. Expert Opin Drug Deliv.12:653–667.
   PubMed Web of Science ®Google Scholar
• Sharma A, Gautam SP, Gupta AK. 2011. Surface modified dendrimers: synthesis and characterization for cancer targeted drug delivery. Bioorg Med Chem. 19:3341–3346.
   PubMed Web of Science ®Google Scholar
• Sharma P, Mehra NK, Jain K, Jain NK. 2015. Biomedical application of carbon nanotubes: a critical review. Curr Drug Deliv. 12: Epub ahead of print.
   Web of Science ®Google Scholar
• Singh P, Gupta U, Asthana A, Jain NK. 2008. Folate and folate − PEG − PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjugate Chem. 19:2239–2252.
   PubMed Web of Science ®Google Scholar
• Sunoqrot S, Liu Y, Kim DH, Hong S. 2012. In vitro evaluation of dendrimer-polymer hybrid nanoparticles on their controlled cellular targeting kinetics. Mol Pharm. 10:2157–2166.
   PubMed Web of Science ®Google Scholar
• Thakur S, Kesharwani P, Tekade RK, Jain NK. 2015. Impact of PEGylation on biopharmaceutical properties of dendrimers. Polymer. 12:612–620.
   Google Scholar
• Thomas TP, Huang B, Choi SK, Silpe JE, Kotlyar A, Desai AM, et al. 2012. Polyvalent dendrimer-Methotrexate as a folate receptor-targeted cancer therapeutic. Mol Pharm. 9:2669–2676.
   PubMed Web of Science ®Google Scholar
• Wang CF, Makila EM, Kaasalainen MH, Hagström MV, Salonen JJ, Hirvonen JT, Santos HA. 2015. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy. Acta Biomaterial. 16:206–214.
   PubMed Web of Science ®Google Scholar
• Wu G, Barth RF, Yang W, Kawabata S, Zhang L, Green-Church K. 2006. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Mol Cancer Ther. 5:52–59.
   PubMed Web of Science ®Google Scholar